P06340 (DOA_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 122.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: HLA class II histocompatibility antigen, DO alpha chain Alternative name(s): MHC DN-alpha MHC DZ alpha MHC class II antigen DOA | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 250 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Important modulator in the HLA class II restricted antigen presentation pathway by interaction with the HLA-DM molecule in B-cells. Modifies peptide exchange activity of HLA-DM. |
| Subunit structure | Heterodimer of an alpha chain (DOA) and a beta chain (DOB). Forms a heterotetrameric complex with an HLA-DM molecule during intracellular transport in endosomal/lysosomal compartments in B-cells. |
| Subcellular location | Endosome membrane; Single-pass type I membrane protein. Lysosome membrane; Single-pass type I membrane protein. Note: Complexes with HLA-DM molecule during intracellular transport and in endosomal/lysosomal compartments. Heterotetramerization is necessary to exit the ER. |
| Polymorphism | The following alleles of DOA are known: DOA*01:01, DOA*01:02 and DOA*01:03. The sequence shown is that of DOA*01:01. |
| Sequence similarities | Belongs to the MHC class II family. Contains 1 Ig-like C1-type (immunoglobulin-like) domain. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 25 | 25 | Potential | ||||||||||||||||||||||||||||||||||||||
| Chain | 26 – 250 | 225 | HLA class II histocompatibility antigen, DO alpha chain | PRO_0000018962 | |||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||
| Topological domain | 26 – 217 | 192 | Extracellular Potential | ||||||||||||||||||||||||||||||||||||||
| Transmembrane | 218 – 240 | 23 | Helical; Potential | ||||||||||||||||||||||||||||||||||||||
| Topological domain | 241 – 250 | 10 | Cytoplasmic Potential | ||||||||||||||||||||||||||||||||||||||
| Domain | 113 – 205 | 93 | Ig-like C1-type | ||||||||||||||||||||||||||||||||||||||
| Region | 26 – 110 | 85 | Alpha-1 | ||||||||||||||||||||||||||||||||||||||
| Region | 111 – 204 | 94 | Alpha-2 | ||||||||||||||||||||||||||||||||||||||
| Region | 205 – 217 | 13 | Connecting peptide | ||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 104 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||||
| Glycosylation | 144 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 133 ↔ 189 | By similarity | |||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||
| Natural variant | 99 | 1 | L → V in allele DOA*01:03. Corresponds to variant rs41542323 [ dbSNP | Ensembl ]. | VAR_058126 | |||||||||||||||||||||||||||||||||||||
| Natural variant | 105 | 1 | R → C in allele DOA*01:02. Corresponds to variant rs11575906 [ dbSNP | Ensembl ]. | VAR_058127 | |||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||
| Beta strand | 29 – 40 | 12 | |||||||||||||||||||||||||||||||||||||||
| Helix | 42 – 44 | 3 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 45 – 52 | 8 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 55 – 61 | 7 | |||||||||||||||||||||||||||||||||||||||
| Turn | 62 – 65 | 4 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 66 – 71 | 6 | |||||||||||||||||||||||||||||||||||||||
| Helix | 72 – 74 | 3 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 77 – 80 | 4 | |||||||||||||||||||||||||||||||||||||||
| Helix | 87 – 94 | 8 | |||||||||||||||||||||||||||||||||||||||
| Helix | 96 – 102 | 7 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 114 – 121 | 8 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 129 – 141 | 13 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 144 – 149 | 6 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 152 – 154 | 3 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 171 – 179 | 9 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 187 – 192 | 6 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 196 – 198 | 3 | |||||||||||||||||||||||||||||||||||||||
| Beta strand | 200 – 204 | 5 | |||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The human HLA class II alpha chain gene DZ alpha is distinct from genes in the DP, DQ and DR subregions." Trowsdale J., Kelly A. EMBO J. 4:2231-2237(1985) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE DOA*01:01). |
| [2] | "Human class II DNA and DOB genes display low sequence variability." Jonsson A.-K., Rask L. Immunogenetics 29:411-413(1989) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DOA*01:01). |
| [3] | "The HLA-DNA (DZA) gene is correctly expressed as a 1.1 kb mature mRNA transcript." Young J.A., Trowsdale J. Immunogenetics 31:386-388(1990) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DOA*01:01). |
| [4] | "Identification of four novel HLA-DOA alleles, DOA*010106, DOA*0102, DOA*0103, and DOA*0104N, by sequence-based typing." Moon S.-M., Gu H., Ryu H.-J., Kim J.-J., Kim H.-T., Han B.G., Kimm K., Lee J.-K., Oh B. Tissue Antigens 66:242-245(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ALLELES DOA*01:01; DOA*01:02 AND DOA*01:03). |
| [5] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELE DOA*01:01). Tissue: Lung. |
| [6] | "The DNA sequence and analysis of human chromosome 6." Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D., Andrews T.D. Beck S.Nature 425:805-811(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ALLELE DOA*01:01). |
| [7] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ALLELE DOA*01:01). |
| [8] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELE DOA*01:01). Tissue: Lymph. |
| [9] | "Limited polymorphism in the HLA-DOA gene." Naruse T.K., Kawata H., Anzai T., Takashige N., Kagiya M., Nose Y., Nabeya N., Isshiki G., Tatsumi N., Inoko H. Tissue Antigens 53:359-365(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-250 (ALLELE DOA*01:01). |
| [10] | "Nonclassical MHC class II molecules." Alfonso C., Karlsson L. Annu. Rev. Immunol. 18:113-142(2000) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | X02882 Genomic DNA. Translation: CAA26635.1. M26039 mRNA. Translation: AAA59716.1. M31525 mRNA. Translation: AAA60075.1. AY947479 mRNA. Translation: AAX49509.1. AY947480 mRNA. Translation: AAX49510.1. AY947481 mRNA. Translation: AAX49511.1. AK290714 mRNA. Translation: BAF83403.1. AK313551 mRNA. Translation: BAG36327.1. Z81310 Genomic DNA. Translation: CAB03594.1. AL662845 Genomic DNA. Translation: CAI17494.1. AL645931 Genomic DNA. Translation: CAI18036.1. AL805913 Genomic DNA. Translation: CAI18546.1. BX005422 Genomic DNA. Translation: CAM26122.1. CR759829 Genomic DNA. Translation: CAP58470.1. CR936909 Genomic DNA. Translation: CAQ07150.1. CR759795 Genomic DNA. Translation: CAQ07430.1. CH471081 Genomic DNA. Translation: EAX03668.1. BC013183 mRNA. Translation: AAH13183.1. AB005991 Genomic DNA. Translation: BAA81787.1. AB005992 Genomic DNA. Translation: BAA81788.1. AB005993 Genomic DNA. Translation: BAA81789.1. AB005994 Genomic DNA. Translation: BAA81790.1. AB005995 Genomic DNA. Translation: BAA81791.1. AB005996 Genomic DNA. Translation: BAA81792.1. AB005997 Genomic DNA. Translation: BAA81793.1. AB005998 Genomic DNA. Translation: BAA81794.1. | ||||||||||||
| IPI | IPI00026244. | ||||||||||||
| PIR | HLHUDZ. A02216. | ||||||||||||
| RefSeq | NP_002110.1. NM_002119.3. | ||||||||||||
| UniGene | Hs.631991. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | P06340. | ||||||||||||
| ModBase | Search... | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 122210. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | P06340. | ||||||||||||
| PRIDE | P06340. | ||||||||||||
Protocols and materials databases | |||||||||||||
| DNASU | 3111. | ||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000229829; ENSP00000229829; ENSG00000204252. ENST00000383226; ENSP00000372713; ENSG00000206292. ENST00000426070; ENSP00000401504; ENSG00000231558. ENST00000426685; ENSP00000397945; ENSG00000232957. ENST00000434335; ENSP00000416448; ENSG00000232962. ENST00000438987; ENSP00000395737; ENSG00000230141. ENST00000452598; ENSP00000398819; ENSG00000235744. | ||||||||||||
| GeneID | 3111. | ||||||||||||
| KEGG | hsa:3111. | ||||||||||||
| UCSC | uc003ocr.3. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 3111. | ||||||||||||
| GeneCards | GC06M032971. | ||||||||||||
| HGNC | HGNC:4936. HLA-DOA. | ||||||||||||
| HPA | HPA045038. | ||||||||||||
| MIM | 142930. gene. | ||||||||||||
| neXtProt | NX_P06340. | ||||||||||||
| PharmGKB | PA35060. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | NOG45645. | ||||||||||||
| HOVERGEN | HBG006862. | ||||||||||||
| InParanoid | P06340. | ||||||||||||
| KO | K06752. | ||||||||||||
| OMA | KADHMGS. | ||||||||||||
| OrthoDB | EOG4KWJTP. | ||||||||||||
| PhylomeDB | P06340. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| Reactome | REACT_6900. Immune System. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | P06340. | ||||||||||||
| Bgee | P06340. | ||||||||||||
| Genevestigator | P06340. | ||||||||||||
| GermOnline | ENSG00000204252. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| Gene3D | 2.60.40.10. 1 hit. 3.10.320.10. 1 hit. | ||||||||||||
| InterPro | IPR007110. Ig-like_dom. IPR013783. Ig-like_fold. IPR003006. Ig/MHC_CS. IPR003597. Ig_C1-set. IPR011162. MHC_I/II-like_Ag-recog. IPR014745. MHC_II_a/b_N. IPR001003. MHC_II_a_N. [Graphical view] | ||||||||||||
| Pfam | PF07654. C1-set. 1 hit. PF00993. MHC_II_alpha. 1 hit. [Graphical view] | ||||||||||||
| SMART | SM00407. IGc1. 1 hit. SM00920. MHC_II_alpha. 1 hit. [Graphical view] | ||||||||||||
| SUPFAM | SSF54452. MHC_I/II-like_Ag-recog. 1 hit. | ||||||||||||
| PROSITE | PS50835. IG_LIKE. 1 hit. PS00290. IG_MHC. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| GenomeRNAi | 3111. | ||||||||||||
| NextBio | 12345. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | DOA_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P06340 Secondary accession number(s): Q58HU0 Q9TQD3 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 6 Human chromosome 6: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
